awacke1/LOINC-Clinical-Terminology · Datasets at Hugging Face

LOINC_NUM stringlengths 3 8	COMPONENT stringlengths 2 246	PROPERTY stringlengths 1 29	TIME_ASPCT stringlengths 1 15	SYSTEM stringlengths 1 106	SCALE_TYP stringclasses 10 values	METHOD_TYP stringlengths 1 57 ⌀	CLASS stringlengths 2 24	CLASSTYPE int64 1 4	LONG_COMMON_NAME stringlengths 3 254	SHORTNAME stringlengths 2 51 ⌀	EXTERNAL_COPYRIGHT_NOTICE stringlengths 39 2.6k ⌀	STATUS stringclasses 4 values	VersionFirstReleased stringlengths 1 7	VersionLastChanged stringlengths 1 5
9344-3	Coproporphyrin 1/Coproporphyrin.total	MRto	24H	Urine	Qn	null	CHEM	1	Coproporphyrin 1/Coproporphyrin.total [Mass Ratio] in 24 hour Urine	Copro1/Copro total 24h Ur	null	ACTIVE	1.0i	2.7
93443-0	Self-care abilities	Find	Pt	^Patient	Nom	null	CLIN	2	Self-care abilities	Self-care abilities	null	ACTIVE	2.67	2.67
93444-8	Accessibility of home entrance	Find	Pt	^Patient	Nom	null	CLIN	2	Accessibility of home entrance	Access of home entrance	null	ACTIVE	2.67	2.67
93445-5	Accessibility note	Find	Pt	Patient's home	Doc	Nurse	DOC.MISC	2	Accessibility note Patient's home Nurse	Accessibility note Pt's home Nurse	null	ACTIVE	2.67	2.67
93446-3	Accessibility of home interior	Find	Pt	^Patient	Nom	null	CLIN	2	Accessibility of home interior	Access home int	null	ACTIVE	2.67	2.67
93447-1	Home accessibility modification responsible party	Find	Pt	^Patient	Nom	null	CLIN	2	Home accessibility modification responsible party	Home access mod responsible party	null	ACTIVE	2.67	2.67
93448-9	Home accessibility evaluation status	Find	Pt	^Patient	Nom	null	DOC.MISC	2	Home accessibility evaluation status	Home access eval status	null	ACTIVE	2.67	2.67
93449-7	Appointment of legal guardian	Find	Pt	^Patient	Nom	null	ADMIN.PATIENT	2	Appointment of legal guardian	Appt legal guardian	null	ACTIVE	2.67	2.67
9345-0	Coproporphyrin 3	MCnc	Pt	Urine	Qn	null	CHEM	1	Coproporphyrin 3 [Mass/volume] in Urine	Copro3 Ur-mCnc	null	ACTIVE	1.0i	2.73
93450-5	Coagulation factor VIII Inhibitor	ACnc	Pt	PPP	Qn	Chromo	COAG	1	Coagulation factor VIII inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method	Fact VIII Inhib PPP Chro-aCnc	null	ACTIVE	2.67	2.67
93451-3	Nor-W-18+Nor-W-15	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	Nor-W-18+Nor-W-15 [Mass/volume] in Urine by Confirmatory method	Nor-W-18+Nor-W-15 Ur Cfm-mCnc	null	ACTIVE	2.67	2.67
93452-1	W-19	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	W-19 [Mass/volume] in Urine by Confirmatory method	W-19 Ur Cfm-mCnc	null	ACTIVE	2.67	2.67
93453-9	W-15	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	W-15 [Mass/volume] in Urine by Confirmatory method	W-15 Ur Cfm-mCnc	null	ACTIVE	2.67	2.67
93454-7	W-18	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	W-18 [Mass/volume] in Urine by Confirmatory method	W-18 Ur Cfm-mCnc	null	ACTIVE	2.67	2.67
93455-4	IC-26	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	IC-26 [Mass/volume] in Urine by Confirmatory method	IC-26 Ur Cfm-mCnc	null	ACTIVE	2.67	2.67
93456-2	MT-45	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	MT-45 [Mass/volume] in Urine by Confirmatory method	MT-45 Ur Cfm-mCnc	null	ACTIVE	2.67	2.67
93457-0	AH-8529	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	AH-8529 [Mass/volume] in Urine by Confirmatory method	AH-8529 Ur Cfm-mCnc	null	ACTIVE	2.67	2.67
93458-8	AH-8533	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	AH-8533 [Mass/volume] in Urine by Confirmatory method	AH-8533 Ur Cfm-mCnc	null	ACTIVE	2.67	2.67
93459-6	U-47700	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	U-47700 [Mass/volume] in Urine by Confirmatory method	U-47700 Ur Cfm-mCnc	null	ACTIVE	2.67	2.67
93460-4	AH-7921	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	AH-7921 [Mass/volume] in Urine by Confirmatory method	AH-7921 Ur Cfm-mCnc	null	ACTIVE	2.67	2.67
93461-2	4-Methoxybutyrylfentanyl	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	4-Methoxybutyrylfentanyl [Mass/volume] in Urine by Confirmatory method	4-Methbutfentanyl Ur Cfm-mCnc	null	ACTIVE	2.67	2.67
93462-0	Norcarfentanil	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	Norcarfentanil [Mass/volume] in Urine by Confirmatory method	Norcarfentanil Ur Cfm-mCnc	null	ACTIVE	2.67	2.67
93463-8	Ocfentanil	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	Ocfentanil [Mass/volume] in Urine by Confirmatory method	Ocfentanil Ur Cfm-mCnc	null	ACTIVE	2.67	2.67
93464-6	4-Fluorofentanyl	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	p-Fluorofentanyl [Mass/volume] in Urine by Confirmatory method	4-Fluorofentanyl Ur Cfm-mCnc	null	ACTIVE	2.67	2.67
93465-3	3-Methylfentanyl	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	3-Methylfentanyl [Mass/volume] in Urine by Confirmatory method	3-Me-fentanyl Ur Cfm-mCnc	null	ACTIVE	2.67	2.67
93466-1	Valerylfentanyl	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	Valerylfentanyl [Mass/volume] in Urine by Confirmatory method	Valerylfentanyl Ur Cfm-mCnc	null	ACTIVE	2.67	2.67
93467-9	Butyrylfentanyl	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	Butyrylfentanyl [Mass/volume] in Urine by Confirmatory method	Butyrylfentanyl Ur Cfm-mCnc	null	ACTIVE	2.67	2.67
9346-8	Lipoprotein.beta	MCnc	Pt	Ser/Plas	Qn	Calculated	CHEM	1	Lipoprotein.beta [Mass/volume] in Serum or Plasma by calculation	LDL SerPl Calc-mCnc	null	ACTIVE	1.0i	2.73
93468-7	Acrylfentanyl	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	Acrylfentanyl [Mass/volume] in Urine by Confirmatory method	Acrylfentanyl Ur Cfm-mCnc	null	ACTIVE	2.67	2.67
93469-5	4-Fluorobutyrylfentanyl	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	4-Fluorobutyrylfentanyl [Mass/volume] in Urine by Confirmatory method	4-Fluorobutyrylfentanyl Ur Cfm-mCnc	null	ACTIVE	2.67	2.67
93470-3	Furanylfentanyl	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	Furanylfentanyl [Mass/volume] in Urine by Confirmatory method	Furanylfentanyl Ur Cfm-mCnc	null	ACTIVE	2.67	2.67
93471-1	Acetyl norfentanyl	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	Acetyl norfentanyl [Mass/volume] in Urine by Confirmatory method	Acetyl norfentanyl Ur Cfm-mCnc	null	ACTIVE	2.67	2.67
93472-9	4-Methylphenethylacetylfentanyl	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	4-Methylphenethylacetylfentanyl [Mass/volume] in Urine by Confirmatory method	4-MetPhenEthAcetFentanyl Ur Cfm-mCnc	null	ACTIVE	2.67	2.67
93473-7	Beta hydroxythiofentanyl	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	Beta hydroxythiofentanyl [Mass/volume] in Urine by Confirmatory method	B-OH thiofentanyl Ur Cfm-mCnc	null	ACTIVE	2.67	2.67
93474-5	Synthetic opioids panel	-	Pt	Urine	-	Confirm	PANEL.DRUG/TOX	1	Synthetic opioids panel - Urine by Confirmatory method	Synthetic opioids pnl Ur Cfm	null	ACTIVE	2.67	2.67
93475-2	Busulfan clearance	VRatCnt	Stdy	Plas	Qn	null	DRUG/TOX	1	Busulfan clearance from plasma over study	Busulfan Cl from Plas	null	ACTIVE	2.67	2.67
9347-6	pH.combined acid	LsCnc	Pt	Gast fld	Qn	null	CHEM	1	pH combined acid of Gastric fluid	pH Combined Ac Gast	null	ACTIVE	1.0i	2.42
93476-0	Busulfan	TmSCnc	Stdy	Plas	Qn	null	DRUG/TOX	1	Busulfan [Area under the curve] in Plasma	Busulfan Plas-AUC	null	ACTIVE	2.67	2.67
93477-8	Busulfan given	Mass	XXX	Dose	Qn	null	DRUGDOSE	1	Busulfan given [Mass] of Dose	Busulfan Gvn ?Tm Dose	null	ACTIVE	2.67	2.68
93478-6	Busulfan area under the curve panel	-	Stdy	Plas	Qn	null	PANEL.DRUG/TOX	1	Busulfan area under the curve panel - Plasma	Busulfan AUC Pnl Plas	null	ACTIVE	2.67	2.67
93479-4	Observation interpretation	Imp	Pt	XXX	Nom	null	MISC	1	Observation interpretation	Observation Imp	null	ACTIVE	2.67	2.69
93480-2	Cortisol post corticotropin releasing hormone stimulation panel	-	Pt	Ser/Plas	Qn	null	PANEL.CHAL	1	Cortisol post CRH stimulation panel - Serum or Plasma	Cortisol p CRH stimulation Pnl SerPl	null	ACTIVE	2.67	2.67
93481-0	Cortisol^10M post 1 ug/kg CRH IV	MCnc	Pt	Ser/Plas	Qn	null	CHAL	1	Cortisol [Mass/volume] in Serum or Plasma --10 minutes post 1 ug/kg CRH IV	Cortis 10M p 1 ug/kg CRH IV SerPl-mCnc	null	ACTIVE	2.67	2.67
93482-8	Cortisol^1M pre 1 ug/kg CRH IV	MCnc	Pt	Ser/Plas	Qn	null	CHAL	1	Cortisol [Mass/volume] in Serum or Plasma --1 minute pre 1 ug/kg CRH IV	Cortis 1M pre 1 ug/kg CRH IV SerPl-mCnc	null	ACTIVE	2.67	2.67
93483-6	Cortisol^2M post 1 ug/kg CRH IV	MCnc	Pt	Ser/Plas	Qn	null	CHAL	1	Cortisol [Mass/volume] in Serum or Plasma --2 minutes post 1 ug/kg CRH IV	Cortis 2M p 1 ug/kg CRH IV SerPl-mCnc	null	ACTIVE	2.67	2.67
9348-4	pH.free acid	LsCnc	Pt	Gast fld	Qn	null	CHEM	1	pH free acid of Gastric fluid	pH Free Ac Gast	null	ACTIVE	1.0i	2.73
93484-4	Cortisol^5M pre 1 ug/kg CRH IV	MCnc	Pt	Ser/Plas	Qn	null	CHAL	1	Cortisol [Mass/volume] in Serum or Plasma --5 minutes pre 1 ug/kg CRH IV	Cortis 5M pre 1 ug/kg CRH IV SerPl-mCnc	null	ACTIVE	2.67	2.67
93485-1	Columbia - suicide severity rating scale - very young child or cognitively impaired - lifetime recent	-	Pt	^Patient	-	C-SSRS	PANEL.SURVEY.CSSRS	4	Columbia - suicide severity rating scale - very young child or cognitively impaired - lifetime recent [C-SSRS]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.68
93486-9	Has subject engaged in self-injurious behavior, intent unknown	Find	3Mo	^Patient	Ord	null	SURVEY.CSSRS	4	Has subject engaged in self-injurious behavior, intent unknown 3 months	null	null	ACTIVE	2.67	2.67
93487-7	Has subject engaged in self-injurious behavior, intent unknown	Find	Lifetime	^Patient	Ord	null	SURVEY.CSSRS	4	Has subject engaged in self-injurious behavior, intent unknown Lifetime	null	null	ACTIVE	2.67	2.67
93488-5	Guanidinoacetate	SCnc	Pt	Bld.dot	Qn	null	CHEM	1	Guanidinoacetate [Moles/volume] in DBS	Guanidinoacetate DBS-sCnc	null	ACTIVE	2.67	2.67
93489-3	Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG	PrThr	Pt	Ser/Plas	Ord	CBA IFA	SERO	1	AMPAR2 IgG Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay	AMPAR2 IgG SerPl Ql CBA IFA	null	ACTIVE	2.67	2.69
93490-1	Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG	Titr	Pt	Ser/Plas	Qn	IF	SERO	1	AMPAR2 IgG Ab [Titer] in Serum or Plasma by Immunofluorescence	AMPAR2 IgG Titr SerPl IF	null	ACTIVE	2.67	2.67
93491-9	Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG	PrThr	Pt	CSF	Ord	CBA IFA	SERO	1	AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay	AMPAR2 IgG CSF Ql CBA IFA	null	ACTIVE	2.67	2.69
9349-2	pH.total acid	LsCnc	Pt	Gast fld	Qn	null	CHEM	1	pH total acid of Gastric fluid	pH Total Ac Gast	null	ACTIVE	1.0i	2.42
93492-7	Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG	Titr	Pt	CSF	Qn	IF	SERO	1	AMPAR2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence	AMPAR2 IgG Titr CSF IF	null	ACTIVE	2.67	2.67
93493-5	3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Ab.IgG	ACnc	Pt	Ser	Qn	IA	CHEM	1	3-Hydroxy-3-Methylglutaryl-coenzyme A reductase IgG Ab [Units/volume] in Serum by Immunoassay	HMGCR IgG Ser IA-aCnc	null	ACTIVE	2.67	2.67
93494-3	Buprenorphine	PrThr	Pt	Urine	Ord	Screen	DRUG/TOX	1	Buprenorphine [Presence] in Urine by Screen method	Buprenorphine Ur Ql Scn	null	ACTIVE	2.67	2.67
93495-0	2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine	PrThr	Pt	Urine	Ord	Screen	DRUG/TOX	1	2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine by Screen method	EDDP Ur Ql Scn	null	ACTIVE	2.67	2.67
93496-8	Nortriptyline	PrThr	Pt	Urine	Ord	Screen	DRUG/TOX	1	Nortriptyline [Presence] in Urine by Screen method	Nortrip Ur Ql Scn	null	ACTIVE	2.67	2.67
93497-6	Moxifloxacin 3.0 ug/mL	Susc	Pt	Isolate	OrdQn	Method for Slow-growing mycobacteria	ABXBACT	1	Moxifloxacin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria	Moxifloxacin 3 ug/mL Islt SlowMyco	null	ACTIVE	2.67	2.67
93498-4	Metabotropic glutamate receptor 1 Ab.IgG	PrThr	Pt	Ser	Ord	CBA IFA	SERO	1	Metabotropic glutamate receptor 1 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay	mGluR1 IgG Ser Ql CBA IFA	null	ACTIVE	2.67	2.69
93499-2	Metabotropic glutamate receptor 1 Ab.IgG	Titr	Pt	Ser	Qn	IF	SERO	1	Metabotropic glutamate receptor 1 IgG Ab [Titer] in Serum by Immunofluorescence	mGluR1 IgG Titr Ser IF	null	ACTIVE	2.67	2.67
93-5	Cefodizime	Susc	Pt	Isolate	OrdQn	Agar diffusion	ABXBACT	1	Cefodizime [Susceptibility] by Disk diffusion (KB)	Cefodizime Islt KB	null	ACTIVE	1.0	2.19
9350-0	Sulfhydryls	PrThr	Pt	Urine	Ord	null	CHEM	1	Sulfhydryls [Presence] in Urine	Sulfhydryls Ur Ql	null	ACTIVE	1.0i	2.56
93500-7	Metabotropic glutamate receptor 1 Ab.IgG	PrThr	Pt	CSF	Ord	CBA IFA	SERO	1	Metabotropic glutamate receptor 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay	mGluR1 IgG CSF Ql CBA IFA	null	ACTIVE	2.67	2.69
93501-5	Metabotropic glutamate receptor 1 Ab.IgG	Titr	Pt	CSF	Qn	IF	SERO	1	Metabotropic glutamate receptor 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence	mGluR1 IgG Titr CSF IF	null	ACTIVE	2.67	2.67
93502-3	N-methyl-D-aspartate receptor subunit 1 Ab.IgG	PrThr	Pt	CSF	Ord	CBA IFA	SERO	1	NMDAR subunit 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay	NMDAR1 IgG CSF Ql CBA IFA	null	ACTIVE	2.67	2.69
93503-1	N-methyl-D-aspartate receptor subunit 1 Ab.IgG	PrThr	Pt	Ser	Ord	CBA IFA	SERO	1	NMDAR subunit 1 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay	NMDAR1 IgG Ser Ql CBA IFA	null	ACTIVE	2.67	2.69
93504-9	Cholesterol crystals	PrThr	Pt	Calculus	Ord	XR diffraction	CHEM	1	Cholesterol crystals [Presence] in Stone by X-ray diffraction	Cholest Cry Stone Ql XR diff	null	ACTIVE	2.67	2.67
93505-6	Heptacarboxylporphyrin I	SRat	24H	Urine	Qn	null	CHEM	1	Heptacarboxylporphyrin I [Moles/time] in 24 hour Urine	Hepta-CP I 24h Ur-sRate	null	ACTIVE	2.67	2.67
93506-4	Heptacarboxylporphyrin III	SRat	24H	Urine	Qn	null	CHEM	1	Heptacarboxylporphyrin III [Moles/time] in 24 hour Urine	Hepta-CP3 24h Ur-sRate	null	ACTIVE	2.67	2.67
93507-2	Hexacarboxylporphyrin I	SRat	24H	Urine	Qn	null	CHEM	1	Hexacarboxylporphyrin I [Moles/time] in 24 hour Urine	Hexa-CP I 24h Ur-sRate	null	ACTIVE	2.67	2.67
93508-0	Hexacarboxylporphyrin III	SRat	24H	Urine	Qn	null	CHEM	1	Hexacarboxylporphyrin III [Moles/time] in 24 hour Urine	Hexa-CPr3 24h Ur-sRate	null	ACTIVE	2.67	2.67
93509-8	Pentacarboxylporphyrin I	SRat	24H	Urine	Qn	null	CHEM	1	Pentacarboxylporphyrin I [Moles/time] in 24 hour Urine	Penta-CPI 24h Ur-sRate	null	ACTIVE	2.67	2.67
93510-6	Pentacarboxylporphyrin III	SRat	24H	Urine	Qn	null	CHEM	1	Pentacarboxylporphyrin III [Moles/time] in 24 hour Urine	Penta-CP3 24h Ur-sRate	null	ACTIVE	2.67	2.67
93511-4	Rickettsia rickettsii & Coxiella burnetii phase 1 & Coxiella burnetii phase 2 Ab.IgG panel	-	Pt	Ser	-	null	PANEL.MICRO	1	Rickettsia rickettsii and Coxiella burnetii phase 1 and Coxiella burnetii phase 2 IgG panel - Serum	R. rickettsii + C. burnetii 1 2 IgG Pnl	null	ACTIVE	2.67	2.67
9351-8	ALPRAZolam	PrThr	Pt	Urine	Ord	null	DRUG/TOX	1	ALPRAZolam [Presence] in Urine	Alpraz Ur Ql	null	ACTIVE	1.0i	2.73
9352-6	Amphetamines	MCnt	Pt	Hair	Qn	null	DRUG/TOX	1	Amphetamines [Mass/mass] in Hair	Amphetamines Hair-mCnt	null	ACTIVE	1.0i	2.73
9353-4	Baclofen	MCnc	Pt	Ser/Plas	Qn	null	DRUG/TOX	1	Baclofen [Mass/volume] in Serum or Plasma	Baclofen SerPl-mCnc	null	ACTIVE	1.0i	2.73
9354-2	Benztropine	MCnc	Pt	Urine	Qn	null	DRUG/TOX	1	Benztropine [Mass/volume] in Urine	Benztropine Ur-mCnc	null	ACTIVE	1.0i	2.7
9355-9	Bumetanide	MCnc	Pt	Ser/Plas	Qn	null	DRUG/TOX	1	Bumetanide [Mass/volume] in Serum or Plasma	Bumetanide SerPl-mCnc	null	ACTIVE	1.0i	2.7
9356-7	busPIRone	MCnc	Pt	Ser/Plas	Qn	null	DRUG/TOX	1	busPIRone [Mass/volume] in Serum or Plasma	busPIRone SerPl-mCnc	null	ACTIVE	1.0i	2.73
935-7	Blood product unit expiration	TmStp	Pt	^BPU	Qn	null	BLDBK	1	Blood product unit expiration [Date and time]	BPU Expire Date BPU	null	ACTIVE	1.0	2.73
9357-5	Disulfiram	MCnc	Pt	Urine	Qn	null	DRUG/TOX	1	Disulfiram [Mass/volume] in Urine	Disulfiram Ur-mCnc	null	ACTIVE	1.0i	2.73
9358-3	Lithium	MCnc	Pt	Saliva	Qn	null	DRUG/TOX	1	Lithium [Mass/volume] in Saliva (oral fluid)	Lithium Sal-mCnc	null	ACTIVE	1.0i	2.73
9359-1	Tacrine	MCnc	Pt	Ser/Plas	Qn	null	DRUG/TOX	1	Tacrine [Mass/volume] in Serum or Plasma	Tacrine SerPl-mCnc	null	ACTIVE	1.0i	2.73
93598-1	Intensity of ideation	-	Pt	^Patient	-	C-SSRS.PCI	PANEL.SURVEY.CSSRS	4	Intensity of ideation [C-SSRS.PCI]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.67
93599-9	Frequency of most severe suicidal ideation	Find	1Mo	^Patient	Ord	C-SSRS.PCI	SURVEY.CSSRS	4	Frequency of most severe suicidal ideation 1 month [C-SSRS.PCI]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.67
93600-5	Frequency of most severe suicidal ideation	Find	Lifetime	^Patient	Ord	C-SSRS.PCI	SURVEY.CSSRS	4	Frequency of most severe suicidal ideation Lifetime [C-SSRS.PCI]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.67
93603-9	Multisection^WO & W contrast IV	Find	Pt	Head & Neck>Spine.cervical	Doc	CT	RAD	2	CT Head and Cervical spine WO and W contrast IV	CT Head+C-spine WO+W contr IV	null	ACTIVE	2.67	2.67
93604-7	Multisection	Find	Pt	Lower extremity.bilateral>Lower extremity arteries+Lower extremity veins	Doc	US.doppler	RAD	2	US.doppler Lower extremity arteries+veins - bilateral	DOP LE aa+vv-Bl	null	ACTIVE	2.67	2.67
93605-4	Views 2 or 3	Find	Pt	Head>Skull & Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar & Pelvis>Sacrum+Coccyx	Doc	XR	RAD	2	XR Skull to Coccyx 2 or 3 Views	XR Skull to Coccyx 2V or 3V	null	ACTIVE	2.67	2.67
93606-2	Views 4 or 5	Find	Pt	Head>Skull & Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar & Pelvis>Sacrum+Coccyx	Doc	XR	RAD	2	XR Skull to Coccyx 4 or 5 Views	XR Skull to Coccyx 4V or 5V	null	ACTIVE	2.67	2.67
93607-0	Views GE 6	Find	Pt	Head>Skull & Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar & Pelvis>Sacrum+Coccyx	Doc	XR	RAD	2	XR Skull to Coccyx GE 6 Views	XR Skull to Coccyx GE 6V	null	ACTIVE	2.67	2.67
93608-8	Atrial contraction strain rate.max	ARat	Pt	Heart.ventricle.left	Qn	US.3D	CARD.US	2	Left ventricular Maximum atrial contraction strain rate by US 3D	LV Max atrial contract strain rate 3D US	null	ACTIVE	2.67	2.67
9360-9	Bartonella quintana Ab.IgG	Titr	Pt	Ser	Qn	null	MICRO	1	Bartonella quintana IgG Ab [Titer] in Serum	B quintana IgG Titr Ser	null	ACTIVE	1.0i	2.73
93609-6	Atrial contraction strain rate.circumferential.max	LenRto	Pt	Heart.ventricle.left	Qn	US.3D	CARD.US	2	Left ventricular Maximum circumferential atrial contraction strain rate by US 3D	LV Max circ atrial contract st rt 3D US	null	ACTIVE	2.67	2.67
93610-4	Atrial contraction strain rate.longitudinal.max	ARat	Pt	Heart.ventricle.left	Qn	US.3D	CARD.US	2	Left ventricular Maximum longitudinal atrial contraction strain rate by US 3D	LV Max long atrial contract str rt 3D US	null	ACTIVE	2.67	2.67
93611-2	Circumferential strain rate.early diastole.max	ARat	Pt	Heart.ventricle.left	Qn	US.3D	CARD.US	2	Left ventricular Maximum circumferential strain rate during early diastole by US 3D	LV Max circ strain rate early dias 3D US	null	ACTIVE	2.67	2.67

9344-3

Coproporphyrin 1/Coproporphyrin.total

MRto

24H

Urine

Qn

null

CHEM

1

Coproporphyrin 1/Coproporphyrin.total [Mass Ratio] in 24 hour Urine

Copro1/Copro total 24h Ur

null

ACTIVE

1.0i

2.7

93443-0

Self-care abilities

Find

Pt

^Patient

Nom

null

CLIN

2

Self-care abilities

null

ACTIVE

2.67

93444-8

Accessibility of home entrance

Find

Pt

^Patient

Nom

null

CLIN

2

Accessibility of home entrance

Access of home entrance

null

ACTIVE

2.67

93445-5

Accessibility note

Find

Pt

Patient's home

Doc

Nurse

DOC.MISC

2

Accessibility note Patient's home Nurse

Accessibility note Pt's home Nurse

null

ACTIVE

2.67

93446-3

Accessibility of home interior

Find

Pt

^Patient

Nom

null

CLIN

2

Accessibility of home interior

Access home int

null

ACTIVE

2.67

93447-1

Home accessibility modification responsible party

Find

Pt

^Patient

Nom

null

CLIN

2

Home accessibility modification responsible party

Home access mod responsible party

null

ACTIVE

2.67

93448-9

Home accessibility evaluation status

Find

Pt

^Patient

Nom

null

DOC.MISC

2

Home accessibility evaluation status

Home access eval status

null

ACTIVE

2.67

93449-7

Appointment of legal guardian

Find

Pt

^Patient

Nom

null

ADMIN.PATIENT

2

Appointment of legal guardian

Appt legal guardian

null

ACTIVE

2.67

9345-0

Coproporphyrin 3

MCnc

Pt

Urine

Qn

null

CHEM

1

Coproporphyrin 3 [Mass/volume] in Urine

Copro3 Ur-mCnc

null

ACTIVE

1.0i

2.73

93450-5

Coagulation factor VIII Inhibitor

ACnc

Pt

PPP

Qn

Chromo

COAG

1

Coagulation factor VIII inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method

Fact VIII Inhib PPP Chro-aCnc

null

ACTIVE

2.67

93451-3

Nor-W-18+Nor-W-15

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

Nor-W-18+Nor-W-15 [Mass/volume] in Urine by Confirmatory method

Nor-W-18+Nor-W-15 Ur Cfm-mCnc

null

ACTIVE

2.67

93452-1

W-19

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

W-19 [Mass/volume] in Urine by Confirmatory method

W-19 Ur Cfm-mCnc

null

ACTIVE

2.67

93453-9

W-15

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

W-15 [Mass/volume] in Urine by Confirmatory method

W-15 Ur Cfm-mCnc

null

ACTIVE

2.67

93454-7

W-18

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

W-18 [Mass/volume] in Urine by Confirmatory method

W-18 Ur Cfm-mCnc

null

ACTIVE

2.67

93455-4

IC-26

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

IC-26 [Mass/volume] in Urine by Confirmatory method

IC-26 Ur Cfm-mCnc

null

ACTIVE

2.67

93456-2

MT-45

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

MT-45 [Mass/volume] in Urine by Confirmatory method

MT-45 Ur Cfm-mCnc

null

ACTIVE

2.67

93457-0

AH-8529

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

AH-8529 [Mass/volume] in Urine by Confirmatory method

AH-8529 Ur Cfm-mCnc

null

ACTIVE

2.67

93458-8

AH-8533

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

AH-8533 [Mass/volume] in Urine by Confirmatory method

AH-8533 Ur Cfm-mCnc

null

ACTIVE

2.67

93459-6

U-47700

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

U-47700 [Mass/volume] in Urine by Confirmatory method

U-47700 Ur Cfm-mCnc

null

ACTIVE

2.67

93460-4

AH-7921

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

AH-7921 [Mass/volume] in Urine by Confirmatory method

AH-7921 Ur Cfm-mCnc

null

ACTIVE

2.67

93461-2

4-Methoxybutyrylfentanyl

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

4-Methoxybutyrylfentanyl [Mass/volume] in Urine by Confirmatory method

4-Methbutfentanyl Ur Cfm-mCnc

null

ACTIVE

2.67

93462-0

Norcarfentanil

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

Norcarfentanil [Mass/volume] in Urine by Confirmatory method

Norcarfentanil Ur Cfm-mCnc

null

ACTIVE

2.67

93463-8

Ocfentanil

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

Ocfentanil [Mass/volume] in Urine by Confirmatory method

Ocfentanil Ur Cfm-mCnc

null

ACTIVE

2.67

93464-6

4-Fluorofentanyl

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

p-Fluorofentanyl [Mass/volume] in Urine by Confirmatory method

4-Fluorofentanyl Ur Cfm-mCnc

null

ACTIVE

2.67

93465-3

3-Methylfentanyl

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

3-Methylfentanyl [Mass/volume] in Urine by Confirmatory method

3-Me-fentanyl Ur Cfm-mCnc

null

ACTIVE

2.67

93466-1

Valerylfentanyl

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

Valerylfentanyl [Mass/volume] in Urine by Confirmatory method

Valerylfentanyl Ur Cfm-mCnc

null

ACTIVE

2.67

93467-9

Butyrylfentanyl

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

Butyrylfentanyl [Mass/volume] in Urine by Confirmatory method

Butyrylfentanyl Ur Cfm-mCnc

null

ACTIVE

2.67

9346-8

Lipoprotein.beta

MCnc

Pt

Ser/Plas

Qn

Calculated

CHEM

1

Lipoprotein.beta [Mass/volume] in Serum or Plasma by calculation

LDL SerPl Calc-mCnc

null

ACTIVE

1.0i

2.73

93468-7

Acrylfentanyl

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

Acrylfentanyl [Mass/volume] in Urine by Confirmatory method

Acrylfentanyl Ur Cfm-mCnc

null

ACTIVE

2.67

93469-5

4-Fluorobutyrylfentanyl

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

4-Fluorobutyrylfentanyl [Mass/volume] in Urine by Confirmatory method

4-Fluorobutyrylfentanyl Ur Cfm-mCnc

null

ACTIVE

2.67

93470-3

Furanylfentanyl

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

Furanylfentanyl [Mass/volume] in Urine by Confirmatory method

Furanylfentanyl Ur Cfm-mCnc

null

ACTIVE

2.67

93471-1

Acetyl norfentanyl

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

Acetyl norfentanyl [Mass/volume] in Urine by Confirmatory method

Acetyl norfentanyl Ur Cfm-mCnc

null

ACTIVE

2.67

93472-9

4-Methylphenethylacetylfentanyl

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

4-Methylphenethylacetylfentanyl [Mass/volume] in Urine by Confirmatory method

4-MetPhenEthAcetFentanyl Ur Cfm-mCnc

null

ACTIVE

2.67

93473-7

Beta hydroxythiofentanyl

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

Beta hydroxythiofentanyl [Mass/volume] in Urine by Confirmatory method

B-OH thiofentanyl Ur Cfm-mCnc

null

ACTIVE

2.67

93474-5

Synthetic opioids panel

-

Pt

Urine

-

Confirm

PANEL.DRUG/TOX

1

Synthetic opioids panel - Urine by Confirmatory method

Synthetic opioids pnl Ur Cfm

null

ACTIVE

2.67

93475-2

Busulfan clearance

VRatCnt

Stdy

Plas

Qn

null

DRUG/TOX

1

Busulfan clearance from plasma over study

Busulfan Cl from Plas

null

ACTIVE

2.67

9347-6

pH.combined acid

LsCnc

Pt

Gast fld

Qn

null

CHEM

1

pH combined acid of Gastric fluid

pH Combined Ac Gast

null

ACTIVE

1.0i

2.42

93476-0

Busulfan

TmSCnc

Stdy

Plas

Qn

null

DRUG/TOX

1

Busulfan [Area under the curve] in Plasma

Busulfan Plas-AUC

null

ACTIVE

2.67

93477-8

Busulfan given

Mass

XXX

Dose

Qn

null

DRUGDOSE

1

Busulfan given [Mass] of Dose

Busulfan Gvn ?Tm Dose

null

ACTIVE

2.67

2.68

93478-6

Busulfan area under the curve panel

-

Stdy

Plas

Qn

null

PANEL.DRUG/TOX

1

Busulfan area under the curve panel - Plasma

Busulfan AUC Pnl Plas

null

ACTIVE

2.67

93479-4

Observation interpretation

Imp

Pt

XXX

Nom

null

MISC

1

Observation interpretation

Observation Imp

null

ACTIVE

2.67

2.69

93480-2

Cortisol post corticotropin releasing hormone stimulation panel

-

Pt

Ser/Plas

Qn

null

PANEL.CHAL

1

Cortisol post CRH stimulation panel - Serum or Plasma

Cortisol p CRH stimulation Pnl SerPl

null

ACTIVE

2.67

93481-0

Cortisol^10M post 1 ug/kg CRH IV

MCnc

Pt

Ser/Plas

Qn

null

CHAL

1

Cortisol [Mass/volume] in Serum or Plasma --10 minutes post 1 ug/kg CRH IV

Cortis 10M p 1 ug/kg CRH IV SerPl-mCnc

null

ACTIVE

2.67

93482-8

Cortisol^1M pre 1 ug/kg CRH IV

MCnc

Pt

Ser/Plas

Qn

null

CHAL

1

Cortisol [Mass/volume] in Serum or Plasma --1 minute pre 1 ug/kg CRH IV

Cortis 1M pre 1 ug/kg CRH IV SerPl-mCnc

null

ACTIVE

2.67

93483-6

Cortisol^2M post 1 ug/kg CRH IV

MCnc

Pt

Ser/Plas

Qn

null

CHAL

1

Cortisol [Mass/volume] in Serum or Plasma --2 minutes post 1 ug/kg CRH IV

Cortis 2M p 1 ug/kg CRH IV SerPl-mCnc

null

ACTIVE

2.67

9348-4

pH.free acid

LsCnc

Pt

Gast fld

Qn

null

CHEM

1

pH free acid of Gastric fluid

pH Free Ac Gast

null

ACTIVE

1.0i

2.73

93484-4

Cortisol^5M pre 1 ug/kg CRH IV

MCnc

Pt

Ser/Plas

Qn

null

CHAL

1

Cortisol [Mass/volume] in Serum or Plasma --5 minutes pre 1 ug/kg CRH IV

Cortis 5M pre 1 ug/kg CRH IV SerPl-mCnc

null

ACTIVE

2.67

93485-1

Columbia - suicide severity rating scale - very young child or cognitively impaired - lifetime recent

-

Pt

^Patient

-

C-SSRS

PANEL.SURVEY.CSSRS

4

Columbia - suicide severity rating scale - very young child or cognitively impaired - lifetime recent [C-SSRS]

null

ACTIVE

2.67

2.68

93486-9

Has subject engaged in self-injurious behavior, intent unknown

Find

3Mo

^Patient

Ord

null

SURVEY.CSSRS

4

Has subject engaged in self-injurious behavior, intent unknown 3 months

null

ACTIVE

2.67

93487-7

Has subject engaged in self-injurious behavior, intent unknown

Find

Lifetime

^Patient

Ord

null

SURVEY.CSSRS

4

Has subject engaged in self-injurious behavior, intent unknown Lifetime

null

ACTIVE

2.67

93488-5

Guanidinoacetate

SCnc

Pt

Bld.dot

Qn

null

CHEM

1

Guanidinoacetate [Moles/volume] in DBS

Guanidinoacetate DBS-sCnc

null

ACTIVE

2.67

93489-3

Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG

PrThr

Pt

Ser/Plas

Ord

CBA IFA

SERO

1

AMPAR2 IgG Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay

AMPAR2 IgG SerPl Ql CBA IFA

null

ACTIVE

2.67

2.69

93490-1

Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG

Titr

Pt

Ser/Plas

Qn

IF

SERO

1

AMPAR2 IgG Ab [Titer] in Serum or Plasma by Immunofluorescence

AMPAR2 IgG Titr SerPl IF

null

ACTIVE

2.67

93491-9

Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG

PrThr

Pt

CSF

Ord

CBA IFA

SERO

1

AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

AMPAR2 IgG CSF Ql CBA IFA

null

ACTIVE

2.67

2.69

9349-2

pH.total acid

LsCnc

Pt

Gast fld

Qn

null

CHEM

1

pH total acid of Gastric fluid

pH Total Ac Gast

null

ACTIVE

1.0i

2.42

93492-7

Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG

Titr

Pt

CSF

Qn

IF

SERO

1

AMPAR2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence

AMPAR2 IgG Titr CSF IF

null

ACTIVE

2.67

93493-5

3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Ab.IgG

ACnc

Pt

Ser

Qn

IA

CHEM

1

3-Hydroxy-3-Methylglutaryl-coenzyme A reductase IgG Ab [Units/volume] in Serum by Immunoassay

HMGCR IgG Ser IA-aCnc

null

ACTIVE

2.67

93494-3

Buprenorphine

PrThr

Pt

Urine

Ord

Screen

DRUG/TOX

1

Buprenorphine [Presence] in Urine by Screen method

Buprenorphine Ur Ql Scn

null

ACTIVE

2.67

93495-0

2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine

PrThr

Pt

Urine

Ord

Screen

DRUG/TOX

1

2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine by Screen method

EDDP Ur Ql Scn

null

ACTIVE

2.67

93496-8

Nortriptyline

PrThr

Pt

Urine

Ord

Screen

DRUG/TOX

1

Nortriptyline [Presence] in Urine by Screen method

Nortrip Ur Ql Scn

null

ACTIVE

2.67

93497-6

Moxifloxacin 3.0 ug/mL

Susc

Pt

Isolate

OrdQn

Method for Slow-growing mycobacteria

ABXBACT

1

Moxifloxacin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria

Moxifloxacin 3 ug/mL Islt SlowMyco

null

ACTIVE

2.67

93498-4

Metabotropic glutamate receptor 1 Ab.IgG

PrThr

Pt

Ser

Ord

CBA IFA

SERO

1

Metabotropic glutamate receptor 1 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay

mGluR1 IgG Ser Ql CBA IFA

null

ACTIVE

2.67

2.69

93499-2

Metabotropic glutamate receptor 1 Ab.IgG

Titr

Pt

Ser

Qn

IF

SERO

1

Metabotropic glutamate receptor 1 IgG Ab [Titer] in Serum by Immunofluorescence

mGluR1 IgG Titr Ser IF

null

ACTIVE

2.67

93-5

Cefodizime

Susc

Pt

Isolate

OrdQn

Agar diffusion

ABXBACT

1

Cefodizime [Susceptibility] by Disk diffusion (KB)

Cefodizime Islt KB

null

ACTIVE

1.0

2.19

9350-0

Sulfhydryls

PrThr

Pt

Urine

Ord

null

CHEM

1

Sulfhydryls [Presence] in Urine

Sulfhydryls Ur Ql

null

ACTIVE

1.0i

2.56

93500-7

Metabotropic glutamate receptor 1 Ab.IgG

PrThr

Pt

CSF

Ord

CBA IFA

SERO

1

Metabotropic glutamate receptor 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

mGluR1 IgG CSF Ql CBA IFA

null

ACTIVE

2.67

2.69

93501-5

Metabotropic glutamate receptor 1 Ab.IgG

Titr

Pt

CSF

Qn

IF

SERO

1

Metabotropic glutamate receptor 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence

mGluR1 IgG Titr CSF IF

null

ACTIVE

2.67

93502-3

N-methyl-D-aspartate receptor subunit 1 Ab.IgG

PrThr

Pt

CSF

Ord

CBA IFA

SERO

1

NMDAR subunit 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

NMDAR1 IgG CSF Ql CBA IFA

null

ACTIVE

2.67

2.69

93503-1

N-methyl-D-aspartate receptor subunit 1 Ab.IgG

PrThr

Pt

Ser

Ord

CBA IFA

SERO

1

NMDAR subunit 1 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay

NMDAR1 IgG Ser Ql CBA IFA

null

ACTIVE

2.67

2.69

93504-9

Cholesterol crystals

PrThr

Pt

Calculus

Ord

XR diffraction

CHEM

1

Cholesterol crystals [Presence] in Stone by X-ray diffraction

Cholest Cry Stone Ql XR diff

null

ACTIVE

2.67

93505-6

Heptacarboxylporphyrin I

SRat

24H

Urine

Qn

null

CHEM

1

Heptacarboxylporphyrin I [Moles/time] in 24 hour Urine

Hepta-CP I 24h Ur-sRate

null

ACTIVE

2.67

93506-4

Heptacarboxylporphyrin III

SRat

24H

Urine

Qn

null

CHEM

1

Heptacarboxylporphyrin III [Moles/time] in 24 hour Urine

Hepta-CP3 24h Ur-sRate

null

ACTIVE

2.67

93507-2

Hexacarboxylporphyrin I

SRat

24H

Urine

Qn

null

CHEM

1

Hexacarboxylporphyrin I [Moles/time] in 24 hour Urine

Hexa-CP I 24h Ur-sRate

null

ACTIVE

2.67

93508-0

Hexacarboxylporphyrin III

SRat

24H

Urine

Qn

null

CHEM

1

Hexacarboxylporphyrin III [Moles/time] in 24 hour Urine

Hexa-CPr3 24h Ur-sRate

null

ACTIVE

2.67

93509-8

Pentacarboxylporphyrin I

SRat

24H

Urine

Qn

null

CHEM

1

Pentacarboxylporphyrin I [Moles/time] in 24 hour Urine

Penta-CPI 24h Ur-sRate

null

ACTIVE

2.67

93510-6

Pentacarboxylporphyrin III

SRat

24H

Urine

Qn

null

CHEM

1

Pentacarboxylporphyrin III [Moles/time] in 24 hour Urine

Penta-CP3 24h Ur-sRate

null

ACTIVE

2.67

93511-4

Rickettsia rickettsii & Coxiella burnetii phase 1 & Coxiella burnetii phase 2 Ab.IgG panel

-

Pt

Ser

-

null

PANEL.MICRO

1

Rickettsia rickettsii and Coxiella burnetii phase 1 and Coxiella burnetii phase 2 IgG panel - Serum

R. rickettsii + C. burnetii 1 2 IgG Pnl

null

ACTIVE

2.67

9351-8

ALPRAZolam

PrThr

Pt

Urine

Ord

null

DRUG/TOX

1

ALPRAZolam [Presence] in Urine

Alpraz Ur Ql

null

ACTIVE

1.0i

2.73

9352-6

Amphetamines

MCnt

Pt

Hair

Qn

null

DRUG/TOX

1

Amphetamines [Mass/mass] in Hair

Amphetamines Hair-mCnt

null

ACTIVE

1.0i

2.73

9353-4

Baclofen

MCnc

Pt

Ser/Plas

Qn

null

DRUG/TOX

1

Baclofen [Mass/volume] in Serum or Plasma

Baclofen SerPl-mCnc

null

ACTIVE

1.0i

2.73

9354-2

Benztropine

MCnc

Pt

Urine

Qn

null

DRUG/TOX

1

Benztropine [Mass/volume] in Urine

Benztropine Ur-mCnc

null

ACTIVE

1.0i

2.7

9355-9

Bumetanide

MCnc

Pt

Ser/Plas

Qn

null

DRUG/TOX

1

Bumetanide [Mass/volume] in Serum or Plasma

Bumetanide SerPl-mCnc

null

ACTIVE

1.0i

2.7

9356-7

busPIRone

MCnc

Pt

Ser/Plas

Qn

null

DRUG/TOX

1

busPIRone [Mass/volume] in Serum or Plasma

busPIRone SerPl-mCnc

null

ACTIVE

1.0i

2.73

935-7

Blood product unit expiration

TmStp

Pt

^BPU

Qn

null

BLDBK

1

Blood product unit expiration [Date and time]

BPU Expire Date BPU

null

ACTIVE

1.0

2.73

9357-5

Disulfiram

MCnc

Pt

Urine

Qn

null

DRUG/TOX

1

Disulfiram [Mass/volume] in Urine

Disulfiram Ur-mCnc

null

ACTIVE

1.0i

2.73

9358-3

Lithium

MCnc

Pt

Saliva

Qn

null

DRUG/TOX

1

Lithium [Mass/volume] in Saliva (oral fluid)

Lithium Sal-mCnc

null

ACTIVE

1.0i

2.73

9359-1

Tacrine

MCnc

Pt

Ser/Plas

Qn

null

DRUG/TOX

1

Tacrine [Mass/volume] in Serum or Plasma

Tacrine SerPl-mCnc

null

ACTIVE

1.0i

2.73

93598-1

Intensity of ideation

-

Pt

^Patient

-

C-SSRS.PCI

PANEL.SURVEY.CSSRS

4

Intensity of ideation [C-SSRS.PCI]

null

ACTIVE

2.67

93599-9

Frequency of most severe suicidal ideation

Find

1Mo

^Patient

Ord

C-SSRS.PCI

SURVEY.CSSRS

4

Frequency of most severe suicidal ideation 1 month [C-SSRS.PCI]

null

ACTIVE

2.67

93600-5

Frequency of most severe suicidal ideation

Find

Lifetime

^Patient

Ord

C-SSRS.PCI

SURVEY.CSSRS

4

Frequency of most severe suicidal ideation Lifetime [C-SSRS.PCI]

null

ACTIVE

2.67

93603-9

Multisection^WO & W contrast IV

Find

Pt

Head & Neck>Spine.cervical

Doc

CT

RAD

2

CT Head and Cervical spine WO and W contrast IV

CT Head+C-spine WO+W contr IV

null

ACTIVE

2.67

93604-7

Multisection

Find

Pt

Lower extremity.bilateral>Lower extremity arteries+Lower extremity veins

Doc

US.doppler

RAD

2

US.doppler Lower extremity arteries+veins - bilateral

DOP LE aa+vv-Bl

null

ACTIVE

2.67

93605-4

Views 2 or 3

Find

Pt

Head>Skull & Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar & Pelvis>Sacrum+Coccyx

Doc

XR

RAD

2

XR Skull to Coccyx 2 or 3 Views

XR Skull to Coccyx 2V or 3V

null

ACTIVE

2.67

93606-2

Views 4 or 5

Find

Pt

Head>Skull & Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar & Pelvis>Sacrum+Coccyx

Doc

XR

RAD

2

XR Skull to Coccyx 4 or 5 Views

XR Skull to Coccyx 4V or 5V

null

ACTIVE

2.67

93607-0

Views GE 6

Find

Pt

Head>Skull & Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar & Pelvis>Sacrum+Coccyx

Doc

XR

RAD

2

XR Skull to Coccyx GE 6 Views

XR Skull to Coccyx GE 6V

null

ACTIVE

2.67

93608-8

Atrial contraction strain rate.max

ARat

Pt

Heart.ventricle.left

Qn

US.3D

CARD.US

2

Left ventricular Maximum atrial contraction strain rate by US 3D

LV Max atrial contract strain rate 3D US

null

ACTIVE

2.67

9360-9

Bartonella quintana Ab.IgG

Titr

Pt

Ser

Qn

null

MICRO

1

Bartonella quintana IgG Ab [Titer] in Serum

B quintana IgG Titr Ser

null

ACTIVE

1.0i

2.73

93609-6

Atrial contraction strain rate.circumferential.max

LenRto

Pt

Heart.ventricle.left

Qn

US.3D

CARD.US

2

Left ventricular Maximum circumferential atrial contraction strain rate by US 3D

LV Max circ atrial contract st rt 3D US

null

ACTIVE

2.67

93610-4

Atrial contraction strain rate.longitudinal.max

ARat

Pt

Heart.ventricle.left

Qn

US.3D

CARD.US

2

Left ventricular Maximum longitudinal atrial contraction strain rate by US 3D

LV Max long atrial contract str rt 3D US

null

ACTIVE

2.67

93611-2

Circumferential strain rate.early diastole.max

ARat

Pt

Heart.ventricle.left

Qn

US.3D

CARD.US

2

Left ventricular Maximum circumferential strain rate during early diastole by US 3D

LV Max circ strain rate early dias 3D US

null

ACTIVE

2.67